Inside-Filings
Projekt anfragen

OMEROS CORP (OMER)

Sentiment-Signal

31,2
Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
22.1
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)

Score-Verlauf (90 Tage)

Stammdaten

Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical programs include Narsoplimab (OMS721/MASP-2) that has completed pivotal studies for hematopoietic stem-cell transplant-associated thrombotic microangiopathy (HSCT-TMA); that is in Phase III clinical trial for immunoglobulin A nephropathy (IgAN) and atypical hemolytic uremic syndrome (aHUS); and Phase II clinical trial to treat COVID-19. Its clinical programs also consist of PPAR? (OMS405) that is in Phase II to treat opioid and nicotine addiction; PDE7 (OMS527), which is in Phase I trial for treating addiction and compulsive disorders, and movement disorders; and MASP-3 (OMS906) that is in Phase I trial for paroxysmal nocturnal hemoglobinuria (PNH) and other alternative pathway disorders. The company's preclinical programs comprise MASP-2-small-molecule inhibitors used for the treatment of aHUS, IgAN, HSCT-TMA, and age-related macular degeneration; longer-acting second generation antibody targeting MASP-2; and MASP-3-small-molecule inhibitors to treat PNH and other alternative pathway disorders. Its preclinical programs also include GPR174 Inhibitors and Chimeric Antigen Receptor (CAR) T-Cell and Adoptive T-Cell Therapies for various cancers; and G protein-coupled receptor targets for treating immunologic, immuno-oncologic, metabolic, CNS, cardiovascular, musculoskeletal, and other disorders. The company was incorporated in 1994 and is headquartered in Seattle, Washington.

Unternehmen & Branche

NameOMEROS CORP
TickerOMER
CIK0001285819
BoerseUS
SektorHealthcare
IndustrieBiotechnology
SIC2834 · Pharmaceutical Preparations

Wertpapier & Kennzahlen

CUSIP682143102
ISINUS6821431029
TypCommon Stock
Marktkapitalisierung987,8 Mio. USD
Beta2,53
Dividendenrendite0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2025-12-3110-K-3,350,000-0.05325,632,000-121,231,000
2025-09-3010-Q-30,917,000-0.47185,706,000-220,478,000
2025-06-3010-Q-25,424,000-0.43200,569,000-228,685,000
2025-03-3110-Q-33,460,000-0.58235,161,000-213,553,000
2024-12-3110-K-156,815,000-2.70277,079,000-182,609,000
2024-09-3010-Q-32,232,000-0.56313,335,000-154,172,000
2024-06-3010-Q-56,041,000-0.97356,314,000-124,598,000
2024-03-3110-Q-37,184,000-0.63437,492,000-71,328,000
2023-12-3110-K-117,813,000-1.88378,269,000-24,983,000
2023-09-3010-Q-37,750,000493,071,000-13,952,000
2023-06-3010-Q-37,294,000-0.59527,421,00020,510,000
2023-03-3110-Q-33,701,000-0.54560,132,00054,936,000
2022-12-3110-K47,417,0000.76590,969,00085,684,000
2022-09-3010-Q-17,456,000-0.28457,551,000-46,314,000
2022-06-3010-Q-30,849,000-0.49345,638,000-32,702,000
2022-03-3110-Q-33,011,000-0.53369,263,000-4,925,000
2021-12-3110-K194,235,0003.12419,268,00023,780,000
2021-09-3010-Q30,004,000-22,703,000-0.36123,430,000-262,697,000
2021-06-3010-Q28,823,000-28,593,000-0.46145,391,000-246,296,000
2021-03-3110-Q21,061,000-35,090,000-0.57161,444,000-221,955,000

Fondsaktivität (Vorquartalsvergleich)

FondsAktuell (Stk)Vorquartal (Stk)Veränderung (Stk)Wert (USD)StatusΔTrend
BlackRock, Inc.5,062,43805,062,43886,947,374Neu+100,0%
VANGUARD GROUP INC4,013,31504,013,31568,928,685Neu+100,0%
WHITEBOX ADVISORS LLC18,033,000018,033,00054,031,376Neu+100,0%
D. E. Shaw & Co., Inc.14,134,999014,134,99953,233,295Neu+100,0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP2,494,99502,494,99542,860,305Neu+100,0%
UBS Group AG2,222,98202,222,98238,179,715Neu+100,0%
Context Capital Management, LLC12,209,000012,209,00036,269,609Neu+100,0%
STIFEL FINANCIAL CORP1,809,76601,809,76631,082,740Neu+100,0%
GEODE CAPITAL MANAGEMENT, LLC1,631,35001,631,35028,025,557Neu+100,0%
STATE STREET CORP1,573,52601,573,52627,025,309Neu+100,0%
BANK OF MONTREAL /CAN/1,522,04301,522,04326,141,089Neu+100,0%
CITADEL ADVISORS LLC1,043,35201,043,35217,919,571Neu+100,0%
JANE STREET GROUP, LLC744,2220744,22212,782,013Neu+100,0%
Corient Private Wealth LLC688,0250688,02511,816,830Neu+100,0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC593,2220593,22210,188,588Neu+100,0%
GROUP ONE TRADING LLC589,1690589,16910,118,978Neu+100,0%
NORTHERN TRUST CORP526,7320526,7329,046,622Neu+100,0%
TWO SIGMA INVESTMENTS, LP524,7570524,7579,012,701Neu+100,0%
ROYAL BANK OF CANADA523,2990523,2998,988,000Neu+100,0%
WELLS FARGO & COMPANY/MN6,229,28006,229,2808,870,848Neu+100,0%
Caption Management, LLC475,7000475,7008,170,148Neu+100,0%
MILLENNIUM MANAGEMENT LLC441,8110441,8117,588,104Neu+100,0%
BOOTHBAY FUND MANAGEMENT, LLC388,3000388,3006,669,053Neu+100,0%
MORGAN STANLEY386,1520386,1526,632,161Neu+100,0%
SIMPLEX TRADING, LLC373,1790373,1796,409,348Neu+100,0%
TORONTO DOMINION BANK318,9000318,9005,477,108Neu+100,0%
CAPSTONE INVESTMENT ADVISORS, LLC3,626,30003,626,3004,707,124Neu+100,0%
Focus Partners Wealth3,269,03403,269,0344,673,127Neu+100,0%
Polar Asset Management Partners Inc.268,8000268,8004,616,640Neu+100,0%
Badgley Phelps Wealth Managers, LLC263,5560263,5564,526,575Neu+100,0%
GOLDMAN SACHS GROUP INC227,2940227,2943,903,775Neu+100,0%
WELLINGTON MANAGEMENT GROUP LLP202,6170202,6173,479,947Neu+100,0%
Kynam Capital Management, LP200,0000200,0003,436,000Neu+100,0%
Walleye Capital LLC165,4560165,4562,841,707Neu+100,0%
Invesco Ltd.154,7820154,7822,658,380Neu+100,0%
Walleye Trading LLC148,2530148,2532,546,245Neu+100,0%
BARCLAYS PLC120,4900120,4902,069,416Neu+100,0%
AMERIPRISE FINANCIAL INC117,0040117,0042,009,544Neu+100,0%
BANK OF AMERICA CORP /DE/129,8080129,8081,986,788Neu+100,0%
RHUMBLINE ADVISERS100,1050100,1051,719,287Neu+100,0%
ADAR1 Capital Management, LLC100,0000100,0001,717,500Neu+100,0%
DIMENSIONAL FUND ADVISORS LP96,948096,9481,665,082Neu+100,0%
Susquehanna Portfolio Strategies, LLC92,759092,7591,593,136Neu+100,0%
MML INVESTORS SERVICES, LLC77,875077,8751,337,503Neu+100,0%
ALLIANCEBERNSTEIN L.P.73,490073,4901,262,191Neu+100,0%
AMERICAN FINANCIAL GROUP INC64,113064,1131,101,141Neu+100,0%
Verition Fund Management LLC63,493063,4931,090,492Neu+100,0%
Ancora Advisors LLC59,250059,2501,017,619Neu+100,0%
BRIDGEWAY CAPITAL MANAGEMENT, LLC56,715056,715974,080Neu+100,0%
COLDSTREAM CAPITAL MANAGEMENT INC53,605053,605920,666Neu+100,0%

Insider-Transaktionen (12 Monate)

Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.

Fail-to-Deliver (6 Monate)

DatumFTD-MengeKursWert (USD)
2026-03-31140.7219,811.380.473
2026-03-301.6109,8815.907
2026-03-249.93410,66105.896
2026-03-2327.35611,00300.916
2026-03-1911.61710,95127.206
2026-03-1866.39011,27748.215
2026-03-1723.30211,14259.584
2026-03-163.74211,1941.873
2026-03-1123611,712.764
2026-03-102.41611,2927.277
2026-03-0912.84011,54148.174
2026-03-0634.92011,49401.231
2026-03-059.60211,59111.287
2026-03-0416.21211,64188.708
2026-03-033.68111,9844.098
2026-03-027.31612,0588.158
2026-02-2326.08812,04314.100
2026-02-194.98111,7558.527
2026-02-183.09811,9336.959
2026-02-1761511,697.189

Top-Fondshalter

Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.

FondsAnteileWert (USD)Anteil (%)
BlackRock, Inc.5,062,43886,947,37412.31
VANGUARD GROUP INC4,013,31568,928,6859.76
WHITEBOX ADVISORS LLC18,033,00054,031,3767.65
D. E. Shaw & Co., Inc.14,134,99953,233,2957.54
SUSQUEHANNA INTERNATIONAL GROUP, LLP2,494,99542,860,3056.07
UBS Group AG2,222,98238,179,7155.41
Context Capital Management, LLC12,209,00036,269,6095.14
STIFEL FINANCIAL CORP1,809,76631,082,7404.40
GEODE CAPITAL MANAGEMENT, LLC1,631,35028,025,5573.97
STATE STREET CORP1,573,52627,025,3093.83
BANK OF MONTREAL /CAN/1,522,04326,141,0893.70
CITADEL ADVISORS LLC1,043,35217,919,5712.54
JANE STREET GROUP, LLC744,22212,782,0131.81
Corient Private Wealth LLC688,02511,816,8301.67
CHARLES SCHWAB INVESTMENT MANAGEMENT INC593,22210,188,5881.44
GROUP ONE TRADING LLC589,16910,118,9781.43
NORTHERN TRUST CORP526,7329,046,6221.28
TWO SIGMA INVESTMENTS, LP524,7579,012,7011.28
ROYAL BANK OF CANADA523,2998,988,0001.27
WELLS FARGO & COMPANY/MN6,229,2808,870,8481.26

Hinweis

Erweitert ×